The potential to decrease burden of morbidity and mortality secondary to obesity, DM and cardiovascular diseases is a power GLP-1 RA can help harness to safe resources and improve quality of life as well as life span of populations at risk
Bottom line, retatrutide may end up reshaping how we think about metabolic coverage
The TRAVERSE trial, the first large randomized controlled study on testosterone replacement therapy, demonstrated that modest testosterone doses did not increase cardiovascular event risk in men aged 45-80
Patients should never attempt to self-titrate or source retatrutide outside of a supervised clinical trial setting
Stimulant-related side effects Many patches contain high doses of natural stimulants (like caffeine, green tea extract, or bitter orange) to try and boost metabolism
GLP-1 receptor agonist (incretin mimetic) The pathways GLP-1 S acts on and what each one does